Literature DB >> 15383172

Prevalence of the internalization-associated gene prtF1 in a bacterial population of Streptococcus pyogenes isolated from children with acute pharyngotonsillitis before and after antibiotic therapy.

C E Cocuzza1, A Lanzafame, F Sisto, F Broccolo, R Mattina.   

Abstract

The prevalence of the internalization-associated prtF1 gene was studied in 837 isolates of Streptococcus pyogenes obtained from 713 pediatric patients presenting with acute pharyngotonsillitis before and after antibiotic therapy. Its association with macrolide resistance and with bacteriological treatment failure was determined. The bacterial population isolated from baseline pharyngeal swabs showed an overall prtF1 positivity rate of 33%. A higher prtF1 positivity was found among erythromycin-resistant strains (45%) showing, however, marked differences between the inducible (iMLS), constitutive (cMLS), and efflux pump (M) resistance phenotypes. The prevalence was statistically higher (p < 0.001) in strains belonging to iMLS (84%) and cMLS (67%) phenotypes as compared to the M phenotype (15%). Interestingly, the prevalence of the prtF1 gene was significantly lower (p = 0.04) in strains belonging to M resistance phenotype as compared to erythromycin-susceptible strains (28%). Failed bacterial eradication was demonstrated in 124 patients. The prtF1 positivity rate remained unchanged in strains isolated before and after therapy in patients treated with macrolides (9/54). On the other hand, the positivity rate for the prtF1 gene was significantly higher (p = 0.015) in strains isolated after therapy with beta-lactams (21/70) as compared to baseline isolates (6/70), indicating a differential selection imposed on the organism by these agents. Finally, a high overall eradication rate (88%) of prtF1-positive isolates, belonging to both the erythromycin-susceptible and -resistant phenotypes, was demonstrated following macrolide treatment. Copyright Mary Ann Liebert, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383172     DOI: 10.1089/mdr.2004.10.264

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  5 in total

1.  Survey of phenotypic and genetic features of streptococcus pyogenes strains isolated in Northwest Italy.

Authors:  Simona Bianco; Tiziano Allice; Mario Zucca; Dianella Savoia
Journal:  Curr Microbiol       Date:  2005-12-26       Impact factor: 2.188

2.  Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1, in Streptococcus pyogenes isolates from German pediatric patients.

Authors:  Maria Haller; Kirsten Fluegge; Sandra Jasminder Arri; Brit Adams; Reinhard Berner
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  A foodborne outbreak of a group A streptococcal infection in a Japanese university hospital.

Authors:  Y Takayama; S Hikawa; J Okada; K Sunakawa; T Akahoshi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-21       Impact factor: 3.267

Review 4.  Group A streptococcus and its antibiotic resistance.

Authors:  D Passàli; M Lauriello; G C Passàli; F M Passàli; L Bellussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-02       Impact factor: 2.124

Review 5.  Genital Tract GAS Infection ISIDOG Guidelines.

Authors:  Gilbert Donders; Peter Greenhouse; Francesca Donders; Ulrike Engel; Jorma Paavonen; Werner Mendling
Journal:  J Clin Med       Date:  2021-05-10       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.